Quantitative nanolc/nsi+-hrms method for 1,3-butadiene induced bis-n7-guanine dna-dna cross-links in urine

Luke Erber, Samantha Goodman, Caitlin C. Jokipii Krueger, Ivan Rusyn, Natalia Tretyakova

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


1,3-Butadiene (BD) is a common environmental and industrial chemical widely used in plastic and rubber manufacturing and also present in cigarette smoke and automobile exhaust. BD is classified as a known human carcinogen based on evidence of carcinogenicity in laboratory animals treated with BD by inhalation and epidemiological studies revealing an increased risk of leukemia and lymphohematopoietic cancers in workers occupationally exposed to BD. Upon exposure via inhalation, BD is bioactivated to several toxic epoxides including 3,4-epoxy-1-butene (EB), 3,4-epoxy-1,2-butanediol (EBD), and 1,2,3,4-diepoxybutane (DEB); these are conjugated with glutathione and excreted as 2-(N-acetyl-L-cystein-S-yl)-1-hydroxybut-3-ene/1-(N-acetyl-L-cystein-S-yl)-2-hydroxybut-3-ene (MHBMA), 4-(N-acetyl-L-cystein-S-yl)-1,2-dihydroxybutane (DHBMA), and 1,4-bis-(N-acetyl-L-cystein-S-yl)butane-2,3-diol (bis-BDMA). Exposure to DEB generates monoalky-lated DNA adducts, DNA-DNA crosslinks, and DNA-protein crosslinks, which can cause base substitutions, genomic rearrangements, and large genomic deletions. In this study, we developed a quantitative nanoLC/NSI+-HRMS methodology for 1,4-bis-(gua-7-yl)-2,3-butanediol (bis-N7G-BD) adducts in urine (LOD: 0.1 fmol/mL urine, LOQ: 1.0 fmol/mL urine). This novel method was used to quantify bis-N7G-BD in urine of mice treated with 590 ± 150 ppm BD for 2 weeks (6 h/day, 5 days/week). Bis-N7G-BD was detected in urine of male and female BD-exposed mice (574.6 ± 206.0 and 571.1 ± 163.4 pg/mg of creatinine, respectively). In addition, major urinary metabolites of BD, bis-BDMA, MHBMA and DHBMA, were measured in the same samples. Urinary bis-N7G-BD adduct levels correlated with DEB-derived metabolite bis-BDMA (r = 0.80, Pearson correlation), but not with the EB-derived DNA adducts (EB-GII) or EB-derived metabolites MHBMA and DHBMA (r = 0.24, r = 0.14, r = 0.18, respectively, Pearson correlations). Urinary bis-N7G-BD could be employed as a novel non-invasive biomarker of exposure to BD and bioactivation to its most mutagenic metabolite, DEB. This method will be useful for future studies of 1,3-butadiene exposure and metabolism.

Original languageEnglish (US)
Article number247
Issue number10
StatePublished - Oct 2 2021

Bibliographical note

Funding Information:
Funding: This work was supported, in part, by grants from the National Cancer Institute (R01 CA100670 and P01 CA138338) and the National Institute of Environmental Health Sciences (R01 ES029911 and T32 ES026568). L.E. was partially supported by a training grant from NIH (5K12GM119955).

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.


  • 1,3-butadiene
  • Bis-N7G-BD
  • LC-MS/MS
  • Mercapturic acids
  • Urinary DNA adducts

PubMed: MeSH publication types

  • Journal Article


Dive into the research topics of 'Quantitative nanolc/nsi<sup>+</sup>-hrms method for 1,3-butadiene induced bis-n7-guanine dna-dna cross-links in urine'. Together they form a unique fingerprint.

Cite this